top of page
PAEDIATRIC REPORTING GUIDELINES
Reporting guidelines for trial protocols, reports, interventions,
and systematic reviews that involve children and adolescents (aged 0-19 years)
Trial protocols:
SPIRIT-Children and Adolescents (SPIRIT-C) 2026
Co-published in The BMJ, The Lancet Child and Adolescent Health, and JAMA Pediatrics, SPIRIT-C 2026 presents 17 reporting items to guide the comprehensive and transparent reporting of the minimum set of essential elements in paediatric trial protocols.
Statement:
Explanation and Elaboration (E&E):
Additional resources:
Trial reports:
CONSORT-Children and Adolescents (CONSORT-C) 2026
Co-published in The BMJ, The Lancet Child and Adolescent Health, and JAMA Pediatrics, CONSORT-C 2026 presents 13 reporting items aimed to guide the comprehensive and transparent reporting of the minimum set of essential elements in paediatric trial reports.
Statement:
Explanation and Elaboration (E&E):
Additional resources:
Trial interventions:
TIDieR-Children and Adolescents (TIDieR-C)
Published in Pediatrics, TIDieR-C presents 13 paediatric considerations aimed to support the comprehensive and transparent reporting of trial interventions.
Statement and examples:
Additional resources:
Systematic reviews:
PRISMA-Children and Adolescents (PRISMA-C) 2026
Published in The BMJ, PRISMA-C 2026 presents 7 reporting items, 4 abstract items, and 10 PRISMA 2020 items to which the ontogeny statement applies. PRISMA-C 2026 guides complete reporting of systematic reviews of interventions in paediatrics.
Statement and examples:
Additional resources:
bottom of page